# Methotrexate

## Methotrexate inj 50mg/2mL

| TAH Drug Code      | [IMTX2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMTX2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Antineoplastic agent. It can be used for the treatment of breast cancer, choriocarcinoma, and hydatidiform mole. This drug can be combined with other chemotherapy agents for the palliative treatment of acute leukemia. It can also be used for the treatment of advanced Burkitt's lymphoma (stage IH and IV of the Peter's classification system). In high-dose therapy, it is used to treat epidermoid carcinoma of the neck and head, osteosarcoma, and bronchial carcinoma. High-dose therapy must be used in combination with Calcium folinate (Leucovorin calcium) for rescue.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | [Choriocarcinoma and similar trophoblastic diseases] 15-30 mg orally or intramuscularly daily for a 5-day course repeated for 3-5 times as required with rest periods of 1 or more weeks interposed between courses until any manifesting toxic symptoms subside. [Breast cancer] 40 mg/m2 IV on days 1 and 8 in combination with cyclophosphamide and fluorouracil. [Leukemia] Induction: 3.3 mg/m2 in combination with prednisolone 60 mg/m2 daily for 4-6 weeks. Maintenance therapy: administer 2 times weekly orally or IM in total weekly doses of 30 mg/m2 or 2.5 mg/kg IV every 14 days. If and when relapse occurs, repeat initial induction regimen. [Meningeal Leukemia] 0.2-0.5 mg/kg intrathecally at intervals of 2-5 days until the cell count of the cerebrospinal fluid returns to normal. At this point one additional dose is advisable. Alternative: 12 mg/m2 intrathecally once weekly for 2 weeks, then once monthly. [Lymphomas] 0.625-2.5 mg/kg daily. Treatment in all stages usually consists of several courses interposed with 7-10 day rest periods. 0.625-2.5 mg/kg daily.[Mycosis fungoides] 50 mg IM once weekly or 25 mg IM twice weekly.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Pregnancy & lactation. Psoriatic patient in a poor state of nutrition, serious renal or liver disorders, bone marrow hyperplasia, leukopenia, thrombocytopenia or anemia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | - Skin Disorders: Rash, erythema, pruritus, urticaria, photosensitivity, depigmentation/hyperpigmentation, alopecia, vasculitis, petechiae, ecchymosis, telangiectasia, acne, furunculosis, nail changes, nail hyperpigmentation, acute paronychia, DRESS syndrome. - Hematologic & Lymphatic System: Bone marrow suppression, leukopenia, neutropenia, eosinophilia, pancytopenia, agranulocytosis, thrombocytopenia, anemia (including aplastic anemia), hypogammaglobulinemia, hypoalbuminemia. - Cardiovascular System: Reports include pericarditis, vasculitis, pericardial effusion, cardiac tamponade, pulmonary edema, hypotension, and thromboembolic events (arterial thrombosis, cerebral thrombosis, deep vein thrombosis, retinal vein occlusion, thrombophlebitis, pulmonary embolism). - Gastrointestinal System: Mucositis (gingivitis, pharyngitis, stomatitis, glossitis), decreased appetite, anorexia, nausea, vomiting, diarrhea, abdominal discomfort, hematemesis, melena, gastrointestinal ulcers/bleeding, intestinal perforation, non-infectious peritonitis, pancreatitis, enteritis, acute/chronic hepatotoxicity, hepatic atrophy, necrosis, steatosis, acute hepatitis, hepatotoxicity, periportal fibrosis, chronic fibrosis, cirrhosis, elevated liver enzymes, hypoalbuminemia, increased LDH, liver failure. - Genitourinary System: Renal failure, dysuria, azotemia, cystitis, hematuria, impaired gametogenesis, transient oligospermia, reproductive/menstrual dysfunction, infertility, miscarriage, embryotoxicity, fetal death, severe nephropathy, vaginitis, vaginal discharge, vaginal bleeding, vaginal ulcers, gynecomastia. - Pulmonary System: Interstitial pneumonia (including fatal cases), pleural effusion, pleuritis, interstitial fibrosis, reversible eosinophilic pulmonary infiltrates, pulmonary fibrosis, respiratory failure, chronic interstitial obstructive pulmonary disease, alveolar inflammation, fatal outcomes. - Central Nervous System: Paresthesia, encephalopathy/leukoencephalopathy, headache, dizziness, somnolence, blurred vision, speech disorders (dysarthria, aphasia), cranial nerve palsies, paralysis, coma, cerebral edema. Cases of aphasia, hemiparesis, or seizures may be associated with hemorrhage or intra-arterial administration complications. - Ophthalmic Disorders: Reports of conjunctivitis, ocular discomfort, blurred vision, and severe unexplained visual changes (including transient blindness/vision loss). - Auditory & Vestibular Disorders: Tinnitus. - Infections: Opportunistic infections, sometimes fatal, reported in both oncologic and non-oncologic patients. - Neoplasms (Benign, Malignant, Unspecified): Reports of lymphoma (including reversible cases), tumor lysis syndrome, melanoma, and non-melanoma skin cancers. - General Disorders & Injection Site Reactions: Sudden death, nodules, fever, chills, malaise, fatigue, edema, peripheral edema, injection site reactions, injection site necrosis. |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/methotrexate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

## Methotrexate 2.5mg

| TAH Drug Code      | [OMTX](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMTX)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute lymphoblastic leukemia, Cutaneous T-cell lymphoma (mycosis fungoides, advanced), Gestational trophoblastic neoplasia, Meningeal leukemia, prophylaxis and treatment, Osteosarcoma, Psoriasis, Rheumatoid arthritis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | [Choriocarcinoma and similar trophoblastic diseases] 15-30 mg orally or IM daily for a 5-day course. Repeat 3-5 times as required with rest periods of 1 or more weeks interposed between courses, until any manifesting toxic symptoms subside. [Leukemia] Induction: 3.3 mg/m2 in combination with prednisone 60 mg/m2 daily for 4-6 weeks. Maintenance therapy: orally or IM 2 times weekly intotal weekly doses of 30 mg/m2 or 2.5 mg/kg intravenously every 14 days. If and when relapse occurs, repeat the initial induction regimen. [Lymphomas] 10-25 mg/day orally for 4-8 days. Treatment in all stages usually consists of several courses interposed with 7-10 day rest periods. Lymphosarcomas in Stage III may respond to combined drug therapy with 0.625-2.5 mg/kg daily. [Psoriasis] 10-25 mg orally, IM or IV once weekly or 2.5 mg orally at 12-hour intervals for 3 doses every 1 week until adequate response is achieved. 30 mg/week should not ordinarily be exceeded. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Hypersensitivity to methotrexate, including a history of severe hypersensitivity reactions (eg, anaphylaxis). Lactation. Severe renal impairment (CrCl < 10 mL/min) Alcoholism, alcoholic liver disease, or chronic liver disease. Overt or laboratory evidence of immunodeficiency syndromes. Preexisting blood dyscrasias, such as bone marrow hypoplasia, leukopenia, thrombocytopenia, or significant anemia. Pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Common: Alopecia (0.5-10%), Burning sensation, Photosensitivity (3-10%), Rash (0.2%), Abdominal pain, Diarrhea, Indigestion, Nausea, Stomatitis (Up to 10%), Vomiting, Thrombocytopenia (Up to 10%), Increased liver function test (14-15%), Headache (1.2%), Bronchitis, Nasopharyngitis Serious: Thromboembolic disorder, Erythema multiforme, Skin cancer, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Hemorrhagic enteritis of intestine, Perforation of intestine, Agranulocytosis, Aplastic anemia, Leukopenia (Up to 3%), Pancytopenia (Up to 3%), Cirrhosis of liver (0.1%), Hepatic fibrosis (7%), Hepatitis, Acute, Hepatotoxicity, Anaphylaxis, Malignant lymphoma, Opportunistic infection, Encephalopathy, Leukoencephalopathy, Neurotoxicity, Seizure, Renal failure, Interstitial pneumonia, Pulmonary toxicity, Infectious disease                                                                                                                                  |
| Pregnancy          | Contraindicated – 1st Trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/methotrexate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

